MET and glioblastoma: The prevalence and complexity of MET/HGF signaling in high-grade GBM such as MET amplification, elevated HGF and pathway orchestration through intricate miRNA networks emphasize the importance of novel therapeutic strategies for targeting MET/HGF signaling for optimal therapy.